|
|
|
|
Perioperative
Events
|
|
|
Author
|
n*
|
Patients
With Ischemia by TI-Rd (%)
|
Events:
MI/Death
(%)
|
Ischemia
Positive
RD Scan
Positive
Predictive
Value
|
Normal
Scan
Negative
Predictive
Value
|
Comments
|
|
Vascular
surgery
|
|
Boucher
1985 (119)
|
48
|
16
(33)
|
3
(6)
|
19%
(3/16)
|
100%
(32/32)
|
First
study to define risk of thallium redistribution
|
|
Cutler
1987 (120)
|
116
|
54
(47)
|
11
(10)
|
20%
(11/54)
|
100%
(60/60)
|
Only
aortic surgery
|
|
Fletcher
1988 (121)
|
67
|
15
(22)
|
3
(4)
|
20%
(3/15)
|
100%
(56/56)
|
|
|
Sachs
1988 (122)
|
46
|
14
(31)
|
2
(4)
|
14%(2/14)
|
100%
(24/24)
|
|
|
Eagle
1989 (21)
|
200
|
82
(41)
|
15
(8)
|
16%
(13/82)
|
98%
(61/62)
|
Defined
clinical risk
|
|
McEnroe
1990 (123)
|
95
|
34
(36)
|
7
(7)
|
9%
(3/34)
|
96%
(44/46)
|
Fixed
defects predict events
|
|
Younis
1990 (124)
|
111
|
40
(36)
|
8
(7)
|
15%
(6/40)
|
100%
(51/51)
|
Includes
long-term follow-up
|
|
Mangano
1991 (125)
|
60
|
22
(37)
|
3
(5)
|
5%
(1/22)
|
95%
(19/20)
|
Managing
physicians blinded to scan result
|
|
Strawn
1991 (126)
|
68
|
N/A
|
4
(6)
|
N/A
|
100%
(21/21)
|
|
|
Watters
1991 (127)
|
26
|
15
(58)
|
3
(12)
|
20%
(3/15)
|
100%
(11/11)
|
Includes
echocardiograhic (TEE) studies
|
|
Hendel
1992 (128)
|
327
|
167
(51)
|
28
(9)
|
14%
(23/167)
|
99%
(97/98)
|
Included
long-term follow-up
|
|
Lette
1992 (129)
|
355
|
161
(45)
|
30
(8)
|
17%
(28/161)
|
99%
(160/162)
|
Used
quantitative scan index
|
|
Madsen
1992 (130)
|
65
|
45
(69)
|
5
(8)
|
11%
(5/45)
|
100%
(20/20)
|
|
|
Brown
1993 (131)
|
231
|
77
(33)
|
12
(5)
|
13%
(10/77)
|
99%
(120/121)
|
Prognostic
utility enhanced by combined scan and clinical
factors
|
|
Kresowik
1993 (132)
|
170
|
67
(39)
|
5
(3)
|
4%
(3/67)
|
98%
(64/65)
|
|
|
Baron
1994 (133)
|
457
|
160
(35)
|
22
(5)
|
4%
(7/160)
|
96%
(195/203) NFMI only
|
Did
not analyze for cardiac deaths; no independent
value of scan
|
|
Bry
1994 (134)
|
237
|
110
(46)
|
17
(7)
|
11%
(12/110)
|
100%
(97/97)
|
Cost-effectiveness
data included
|
|
Koutelou
1995 (378)
|
106
|
47
(44)
|
3
(3)
|
6%
(3/47)
|
100%
(49/49)
|
Used
adenosine/SPECT thallium imaging
|
|
Marshall
1995
(387)
|
117
|
55
(47)
|
12
(10)
|
16%
(9/55)
|
97%
(33/34)
|
Used
adenosine thallium and sestamibi. Size of ischemic
defect enhanced prognostic utility
|
|
Van
Damme 1997 (388)
|
142
|
48
(34)
|
3
(2)
|
N/A
|
N/A
|
Used
dobutamine SPECT sestamibi and echocardiographic
imaging. Echocardiographic and nuclear scan prognostic
utility were equivalent
|
|
Nonvascular
surgery†xxxxxx
|
|
Camp
1990 (135)
|
40
|
9
(23)
|
6
(15)
|
67%
(6/9)
|
100%
(23/23)
|
Diabetes
mellitus, renal transplant
|
|
Iqbal
1991 (136)
|
31
|
11
(41)
|
3
(11)
|
27%
(3/11)
|
100%
(20/20)
|
Exercise
86%, diabetes mellitus, pancreas transplant
|
|
Coley
1992 (137)
|
100
|
36
(36)
|
4
(4)
|
8%
(3/36)
|
98%
(63/64)
|
Define
clinical risk factors in patients with known or
suspected CAD
|
|
Shaw
1992 (138)
|
60
|
28
(47)
|
6
(10)
|
21%
(6/28)
|
100%
(19/19)
|
Used
adenosine
|
|
Takase
1993 (139)
|
53
|
15
(28)
|
6
(11)
|
27%
(4/15)
|
100%
(32/32)
|
Patients
with documented or suspected CAD include rest
echocardiogram
|
|
Younis
1994 (140)
|
161
|
50
(31)
|
15
(9)
|
18%
(9/50)
|
98%
(87/89)
|
Intermediate-
to high-risk CAD
|
|
Stratman
1996 (270)
|
229
|
67
(29)
|
10
(4)
|
6%
(4/67)
|
99%
(91/92)
|
Used
dipyridamole sestamibi and noted fixed defect
had more prognostic utility than transient defect
|
